1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Recurrent Endometrial Undifferentiated Carcinoma: new trials by email Literature Review of Recurrent Endometrial Undifferentiated Carcinoma trials Research Report on Recurrent Endometrial Undifferentiated Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer Biopsy, Computed Tomography, Fluorine F 18 Tetrafluoroborate - Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma | Phase 1 | Active not recruiting | Mayo Clinic | 34 | 2017-09-15 | 2026-07-21 |
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms (1) · Neoplasms by Site (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Diseases (1) · Uterine Neoplasms (1)
Biopsy (1) · Magnetic Resonance Spectroscopy (1) · Radionuclide Generators (1) · Sodium Pertechnetate Tc 99m (1) · Specimen Handling (1) · ruxolitinib (1) · sodium-iodide symporter (1)
Mayo Clinic (1)
United States (1)
Jamie N. Bakkum-Gamez, M.D. (1)
R01CA207240 (1)